The Inhaled Nitric Oxide Market is projected to grow to USD 1.62 billion by 2033, up from USD 0.54 billion in 2023, reflecting a compound annual growth rate (CAGR) of 7.41% over the forecast period. This market encompasses the commercial activities related to the production, distribution, and application of inhaled nitric oxide (iNO) for medical purposes. Inhaled nitric oxide serves as a vasodilator and is predominantly used to treat respiratory conditions and related complications. The growth of the market is driven by increasing adoption of iNO in clinical settings and advancements in its therapeutic applications.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Product Type (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Diseases, Acute Respiratory Distress Syndrome, Others)
By Application (Delivery Systems, Gas)
Key players
Air Liquide S.A
Bellerophon Therapeutics
BOC Healthcare
Beyond Air
Halma Plc
Linde Plc
Mallinckrodt plc
Novoteris LLC
Nu-Med plus
VERO Biotech LLC
- Chapter 1. Executive Summary
- Chapter 2. Scope Of The Study
- 2.1. Market Definition
- 2.2. Scope Of The Study
- 2.2.1. Objectives of Report
- 2.2.2. Limitations
- 2.3. Market Structure
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.1.1. Raw End Users Providers
- 4.1.2. Manufacturing Process
- 4.1.3. Distributors/Retailers
- 4.1.4. End-Use Industry
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat Of New Entrants
- 4.2.2. Bargaining Power Of Buyers
- 4.2.3. Bargaining Power Of Suppliers
- 4.2.4. Threat Of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact Of COVID-19 on the Inhaled Nitric Oxide Market
- 4.3.1. Impact on Market Size
- 4.3.2. End-Use Industry Trend, Preferences, and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players' Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- 4.4. Technology Overview
- 12.28. Macro factor
- 4.6. Micro Factor
- 4.7. Demand Supply Gap Analysis of the Inhaled Nitric Oxide Market
- 4.8. Import Analysis of the Inhaled Nitric Oxide Market
- 4.9. Export Analysis of the Inhaled Nitric Oxide Market
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DROC Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- 5.2.4. Challenges
- 5.3. Patent Analysis
- 5.4. Industry Roadmap
- 5.5. Parent/Peer Market Analysis
- Chapter 6. Global Inhaled Nitric Oxide Market, By Product Type
- 6.1. Introduction
- 6.2. Neonatal Respiratory Treatment
- 6.3. Chronic Obstructive Pulmonary Diseases
- 6.4. Acute Respiratory Distress Syndrome
- 6.5. Others
- Chapter 7. Global Inhaled Nitric Oxide Market, By Application
- 7.1. Introduction
- 7.2. Delivery Systems
- 7.3. Gas
- Chapter 8. Global Inhaled Nitric Oxide Market, By Region
- 8.1. Introduction
- 8.2. North America
- 8.2.1. Introduction
- 8.2.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.2.3. Market Size and Forecast, By Country, 2023-2033
- 8.2.4. Market Size and Forecast, By Product Type, 2023-2033
- 8.2.5. Market Size and Forecast, By End User, 2023-2033
- 8.2.6. US
- 8.2.6.1. Introduction
- 8.2.6.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.2.6.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.2.6.4. Market Size and Forecast, By End User, 2023-2033
- 8.2.7. Canada
- 8.2.7.1. Introduction
- 8.2.7.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.2.7.4. Market Size and Forecast, By Product Type, 2023-2033
- 8.2.7.5. Market Size and Forecast, By End User, 2023-2033
- 8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.3.3. Market Size and Forecast, By Country, 2023-2033
- 8.3.4. Market Size and Forecast, By Product Type, 2023-2033
- 8.3.5. Market Size and Forecast, By End User, 2023-2033
- 8.3.6. Germany
- 8.3.6.1. Introduction
- 8.3.6.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.3.6.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.3.6.4. Market Size and Forecast, By End User, 2023-2033
- 8.3.7. France
- 8.3.7.1. Introduction
- 8.3.7.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.3.7.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.3.7.4. Market Size and Forecast, By End User, 2023-2033
- 8.3.8. UK
- 8.3.8.1. Introduction
- 8.3.8.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.3.8.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.3.8.4. Market Size and Forecast, By End User, 2023-2033
- 8.3.9. Italy
- 8.3.9.1. Introduction
- 8.3.9.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.3.9.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.3.9.4. Market Size and Forecast, By End User, 2023-2033
- 8.3.11. Rest Of Europe
- 8.3.11.1. Introduction
- 8.3.11.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.3.11.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.3.11.4. Market Size and Forecast, By End User, 2023-2033
- 8.4. Asia-Pacific
- 8.4.1. Introduction
- 8.4.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.4.3. Market Size and Forecast, By Country, 2023-2033
- 8.4.4. Market Size and Forecast, By Product Type, 2023-2033
- 8.12.28. Market Size and Forecast, By End User, 2023-2033
- 8.4.6. China
- 8.4.6.1. Introduction
- 8.4.6.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.4.6.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.4.6.4. Market Size and Forecast, By End User, 2023-2033
- 8.4.7. India
- 8.4.7.1. Introduction
- 8.4.7.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.4.7.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.4.7.4. Market Size and Forecast, By End User, 2023-2033
- 8.4.8. Japan
- 8.4.8.1. Introduction
- 8.4.8.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.4.8.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.4.8.4. Market Size and Forecast, By End User, 2023-2033
- 8.4.9. South Korea
- 8.4.9.1. Introduction
- 8.4.9.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.4.9.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.4.9.4. Market Size and Forecast, By End User, 2023-2033
- 8.4.10. Rest Of Asia-Pacific
- 8.4.10.1. Introduction
- 8.4.10.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.4.10.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.4.10.4. Market Size and Forecast, By End User, 2023-2033
- 8.5. Rest Of The World (RoW)
- 8.5.1. Introduction
- 8.5.2. Driving Factors, Opportunity Analyzed, and Key Trends
- 8.5.3. Market Size and Forecast, By Product Type, 2023-2033
- 8.5.4. Market Size and Forecast, By End User, 2023-2033
- Chapter 9. Company Landscape
- 9.1. Introduction
- 9.2. Vendor Share Analysis
- 9.3. Key Development Analysis
- 9.4. Competitor Dashboard
- Chapter 10. Company Profiles
- 10.1. Air Liquide S.A
- 10.1.1. Business Overview
- 10.1.2. Government & Defense Analysis
- 10.1.2.1. Government & Defense – Existing/Funding
- 10.1.3. Product Portfolio
- 10.1.4. Recent Development and Strategies Adopted
- 10.1.5. SWOT Analysis
- 10.2. Bellerophon Therapeutics
- 10.2.1. Business Overview
- 10.2.2. Government & Defense Analysis
- 10.2.2.1. Government & Defense – Existing/Funding
- 10.2.3. Product Portfolio
- 10.2.4. Recent Development and Strategies Adopted
- 10.2.5. SWOT Analysis
- 10.3. BOC Healthcare
- 10.3.1. Business Overview
- 10.3.2. Government & Defense Analysis
- 10.3.2.1. Government & Defense – Existing/Funding
- 10.3.3. Product Portfolio
- 10.3.4. Recent Development and Strategies Adopted
- 10.3.5. SWOT Analysis
- 10.4. Beyond Air
- 10.4.1. Business Overview
- 10.4.2. Government & Defense Analysis
- 10.4.2.1. Government & Defense – Existing/Funding
- 10.4.3. Product Portfolio
- 10.4.4. Recent Development and Strategies Adopted
- 10.12.28. SWOT Analysis
- 10.5. Halma Plc
- 10.5.1. Business Overview
- 10.5.2. Government & Defense Analysis
- 10.5.2.1. Government & Defense – Existing/Funding
- 10.5.3. Product Portfolio
- 10.5.4. Recent Development and Strategies Adopted
- 10.5.5. SWOT Analysis
- 10.6. Linde Plc
- 10.6.1. Business Overview
- 10.6.2. Government & Defense Analysis
- 10.6.2.1. Government & Defense – Existing/Funding
- 10.6.3. Product Portfolio
- 10.6.4. Recent Development and Strategies Adopted
- 10.6.5. SWOT Analysis
- 10.7. Mallinckrodt plc
- 10.7.1. Business Overview
- 10.7.2. Government & Defense Analysis
- 10.7.2.1. Government & Defense – Existing/Funding
- 10.7.3. Product Portfolio
- 10.7.4. Recent Development and Strategies Adopted
- 10.7.5. SWOT Analysis
- 10.8 Novoteris LLC
- 10.8.1. Business Overview
- 10.8.2. Government & Defense Analysis
- 10.8.2.1. Government & Defense – Existing/Funding
- 10.8.3. Product Portfolio
- 10.8.4. Recent Development and Strategies Adopted
- 10.8.5. SWOT Analysis
- 10.9 Nu-Med plus
- 10.9.1. Business Overview
- 10.9.2. Government & Defense Analysis
- 10.9.2.1. Government & Defense – Existing/Funding
- 10.9.3. Product Portfolio
- 10.9.4. Recent Development and Strategies Adopted
- 10.9.5. SWOT Analysis
- 10.10. VERO Biotech LLC
- 10.10.1. Business Overview
- 10.10.2. Government & Defense Analysis
- 10.10.2.1. Government & Defense – Existing/Funding
- 10.10.3. Product Portfolio
- 10.10.4. Recent Development and Strategies Adopted
- 10.10.5. SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook